|
MechanismNav1.5 modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hangzhou Rongze Biotechnology Group Co., Ltd.
0 Patents (Medical) associated with Hangzhou Rongze Biotechnology Group Co., Ltd.
100 Deals associated with Hangzhou Rongze Biotechnology Group Co., Ltd.
100 Translational Medicine associated with Hangzhou Rongze Biotechnology Group Co., Ltd.